Edward Neuwelt, MD, Neurosurgery, Portland, OR, VA Portland Healthcare System

EdwardAllenNeuweltMD

Neurosurgery Portland, OR

Professor of Neurological Surgery, Oregon Hlth & Sci Univ

Are you Dr. Neuwelt?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 43 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Edward Neuwelt, MD is a neurosurgeon in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Maryland, and Texas. He is affiliated with VA Portland Healthcare System and OHSU Hospital.

Education & Training

  • University of Texas Southwestern - Parkland Health & Hospital SystemResidency, Neurological Surgery, 1976 - 1978
  • University of MarylandResidency, Internal Medicine, 1974 - 1975
  • University of Texas Southwestern - Parkland Health & Hospital SystemResidency, Neurological Surgery, 1973 - 1974
  • University of Texas Southwestern - Parkland Health & Hospital SystemInternship, Transitional Year, 1972 - 1973
  • University of Colorado Denver School of MedicineClass of 1972

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1981 - 2021
  • MD State Medical License
    MD State Medical License 1975 - 1981
  • TX State Medical License
    TX State Medical License 1973 - 1987
  • CO State Medical License
    CO State Medical License 1973 - 1977
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Portland Monthly Magazine Castle Connolly, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • OHSU School of Medicine Researchers Teach High School Students to Be Scientists
    OHSU School of Medicine Researchers Teach High School Students to Be ScientistsDecember 10th, 2019
  • System May Help Treat Rare Genetic Disorder, Reduce Severe Side Effects
    System May Help Treat Rare Genetic Disorder, Reduce Severe Side EffectsAugust 30th, 2016
  • Wave of the Future?
    Wave of the Future?June 30th, 2016

Grant Support

  • Delivery Issues In Lung Cancer CNS MetastasesVeterans Affairs2012
  • Opening Of The Blood-Brain Barrier To Antitumor AgentsNational Institute Of Neurological Disorders And Stroke2010–2012
  • The Annual Blood-Brain Barrier Consortium MeetingNational Cancer Institute2006–2012
  • The Annual Blood-Brain Barrier Consortium MeetingNational Institute Of Neurological Disorders And Stroke2011
  • Two Compartment Models To Improve Brain Tumor TherapyNational Cancer Institute2008–2011
  • Nanoparticle MR Imaging Of BBB Inflammation At High Tesla In CNS TumorsNational Institute Of Neurological Disorders And Stroke2007–2011
  • Opening Of The Blood Brain Barrier To Antitumor AgentsNational Institute Of Neurological Disorders And Stroke2002–2008
  • CNS Gene Delivery And Imaging In Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke2003–2007
  • Two Compartment Models To Improve Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke1999–2007
  • Ferumoxytol And TumorsNational Center For Research Resources2005
  • Annual Blood-Brain Barrier Consortium MeetingNational Cancer Institute2005
  • MR, Histologic And EM Imaging Of Intravenous Particles To Brain TumorsNational Center For Research Resources2004–2005
  • The Annual Blood Brain Barrier Consortium MeetingNational Cancer Institute2000–2004
  • CNS Gene Delivery And Efficacy In Brain Tumor TherapyNational Institute Of Neurological Disorders And Stroke1996–2001
  • Opening Of The Blood-Brain Barrier To Antitumor AgentsNational Cancer Institute1994–2001
  • Delivery Of Diagnostic And Therapeutic Mabs To CNSNational Institute Of Neurological Disorders And Stroke1995–1998
  • Opening The Blood-Brain Barrier To Antitumor AgentsNational Cancer Institute1993
  • Pathogenesis And Gene Therapy In Gm2-GangliosidosisNational Institute Of Neurological Disorders And Stroke1990–1992
  • Osmotic Opening Of The Blood-Brain BarrierNational Cancer Institute1988–1992
  • Osmotic Opening Of The BBB To Anti-Tumor AgentsNational Cancer Institute1985–1988

Professional Memberships

Hospital Affiliations